Hanmi Science Co.,Ltd Logo

Hanmi Science Co.,Ltd

A holding company managing R&D-focused pharmaceutical, API, and medical device firms.

008930 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 화성시 팔탄면 무하로 214 한미약품(주) 팔탄공단, 화성시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Hanmi Science Co., Ltd. is a holding company that serves as the parent for a group of enterprises in the pharmaceutical and healthcare sectors. The company's operations are conducted through its key subsidiaries, including Hanmi Pharmaceutical, a leading R&D-centric biopharmaceutical firm; Hanmi Fine Chemical, a manufacturer of Active Pharmaceutical Ingredients (APIs); and Hanmi Healthcare, which develops and distributes medical devices. The group collectively engages in the research, development, manufacturing, and sale of a broad portfolio of products, including prescription drugs for various therapeutic areas and innovative medical devices for clinical settings. Hanmi Science provides strategic oversight and management for its subsidiaries, focusing on innovation and fair competition in the pharmaceutical market.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Hanmi Science Co.,Ltd and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-03 00:00
Regulatory News Service
[기재정정]투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 14.0 KB
2025-09-03 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 412.8 KB
2025-09-03 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 410.3 KB
2025-09-03 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 75.2 KB
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 204.6 KB
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 200.2 KB

Automate Your Workflow. Get a real-time feed of all Hanmi Science Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hanmi Science Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America 950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden QUIA
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea 115180
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan 4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan 6098
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan 4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan 6045

Talk to a Data Expert

Have a question? We'll get back to you promptly.